PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Tambourine announces the ALS breakthrough research fund, releases inaugural request for proposals

2023-05-24
(Press-News.org) Washington, DC (May 24) – Tambourine, in partnership with the Milken Institute Center for Strategic Philanthropy, today announced the ALS Breakthrough Research Fund and released the Fund’s first Request for Proposals (RFP). The Fund seeks to change how we understand and treat amyotrophic lateral sclerosis (ALS) by supporting innovative basic and discovery-focused research around the world. It particularly focuses on soliciting and funding creative, high-risk, high-reward ideas that might not otherwise fit existing grant programs but hold the potential to generate breakthrough insights.

ALS is a progressive, fatal, neurodegenerative disease that affects an estimated 350,000 people around the world at any given time. Most people living with ALS survive only two to five years after being diagnosed. Despite common patterns of symptoms, ALS is a highly heterogeneous disease, and the mechanisms that govern its disease onset and progression in most people are either unknown or poorly understood. 

To better understand the current scientific gaps in ALS and opportunities for funders and advocates to make a difference for people living with ALS and their families, Tambourine and the Milken Institute released a major report highlighting critical needs to better understand and cure ALS. The Giving Smarter Guide, released in 2022, offered several promising opportunities where philanthropic investments could uniquely facilitate major advances. The ALS Breakthrough Research Fund builds on the findings of the guide by funding high-risk, high-reward, and innovative discovery-driven research proposals.

“We couldn’t be more honored and hopeful in our pursuit to fund research that could unlock the next big breakthrough in ALS. We’re thrilled to join the growing community of philanthropists focused on accelerating discoveries to ultimately find a cure to this devastating disease,” said Divya Silbermann, Tambourine.

Patients and family advocates, as well as private and public funders, have helped drive significant progress and momentum in the field of ALS over the past two decades. That has ranged from the development of valuable new scientific resources to dozens of clinical trials that have resulted in new therapeutics approved by the US Food and Drug Administration. Nonetheless, there is no known cure for ALS, nor do we know how to prevent its onset. New approaches are sorely needed. 

“Tambourine is providing a new avenue to fund creative and innovative research ideas that will advance our scientific understanding of ALS. The Milken Institute’s analysis has made clear that novel approaches to understanding the fundamental aspects of this disease are lacking, and this Fund seeks to fill that gap,” said Cara Altimus, senior director at the Milken Institute Center for Strategic Philanthropy.

The ALS Breakthrough Research Fund is accepting one-page Letters of Intent (LOI) through Wednesday, June 21, 2023. Applicants must first submit an LOI for consideration and then may be invited to apply for funding up to US$600,000 over two years. The Fund’s full Request for Proposals is available on the Milken Institute’s website. 

Awardees for this cycle of funding should expect to be notified in early December 2023.

###

About Tambourine

Tambourine is the philanthropic initiative of Ben and Divya Silbermann. Drawing inspiration and drive from their family experience with ALS, their work includes funding to address access and inclusion challenges for people living with ALS and their families, as well as research to enable breakthrough scientific discoveries.

About the Milken Institute

The Milken Institute is a nonprofit, nonpartisan think tank focused on accelerating measurable progress on the path to a meaningful life. With a focus on financial, physical, mental, and environmental health, we bring together the best ideas and innovative resourcing to develop blueprints for tackling some of our most critical global issues through the lens of what’s pressing now and what’s coming next. For more information, visit https://milkeninstitute.org/.

About the Center for Strategic Philanthropy

The Milken Institute Center for Strategic Philanthropy advises individuals and foundations seeking to develop and implement transformational giving strategies and offers leadership to make the philanthropic landscape more effective. We conduct deep due diligence across a range of issue areas and identify the areas where philanthropic capital can make the biggest impact and create a better world. For more information, visit our website.

END


ELSE PRESS RELEASES FROM THIS DATE:

MD Anderson Research Highlights for May 24, 2023

2023-05-24
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments include a new treatment option for relapsed/refractory mantle cell lymphoma, a better understanding of protein variants that trigger tumor cell death and activate ...

Study finds daily multivitamin supplements improved memory and slowed cognitive aging in older adults

2023-05-24
Few effective strategies have been shown in randomized clinical trials to improve memory or slow cognitive decline among older adults. Nutritional interventions may play an important role because the brain requires several nutrients for optimal health, and deficiencies in one or more of these nutrients may accelerate cognitive decline. The COcoa Supplement and Multivitamin Outcomes Study (COSMOS), a large-scale nation-wide randomized trial directed by researchers at Brigham and Women’s Hospital (BWH), a founding member of Mass General Brigham, included two separate clinical trials ...

New chemical compound demonstrates potential in nerve regeneration

2023-05-24
Research led by UCL, in partnership with the MRC Laboratory of Molecular Biology (MRC LMB) and AstraZeneca, has identified a new compound that can stimulate nerve regeneration after injury, as well as protect cardiac tissue from the sort of damage seen in heart attack. The study, published in Nature, identified a chemical compound, named ‘1938’, that activates the PI3K signalling pathway, and is involved in cell growth. Results from this early research showed the compound increased neuron growth in nerve cells, and in animal models, it reduced heart tissue damage after major trauma and regenerated lost motor function in a model of nerve injury. Though further research is ...

New research finds dramatic increase in illegal ketamine seized by authorities, sparking concern about potential dangers of rising recreational use

2023-05-24
A new analysis led by NYU Grossman School of Medicine and the National Drug Early Warning System (NDEWS) at the University of Florida found a 349 percent rise in seizures of illicit ketamine by drug enforcement throughout the United States from 2017 through 2022. The study findings suggest that rising use of ketamine, a short-acting dissociative anesthetic commonly prescribed off-label to treat chronic pain and depression, can increase the likelihood that people who use recreationally or who use inadvertently may encounter an adulterated and potentially harmful version of the drug. The study publishes online May 24 in JAMA Psychiatry. “This ...

COVID-19 and risk for mental disorders among adults in Denmark

2023-05-24
About The Study: In this Danish nationwide cohort study, overall risk of new-onset mental disorders in SARS-CoV-2–positive individuals did not exceed the risk among individuals with negative test results (except for those age 70 and older). However, when hospitalized, patients with COVID-19 had markedly increased risk compared with the general population, but comparable to risk among patients hospitalized for non–COVID-19 infections. Future studies should include even longer follow-up time and preferentially ...

Association of community vulnerability and state gun laws with firearm deaths in children and adolescents

2023-05-24
About The Study: In this study including 5,813 youths ages 10 to 19 who died of an assault-related firearm injury, socially vulnerable communities in the U.S. experienced a disproportionate number of assault-related firearm deaths among youths. Although stricter gun laws were associated with lower death rates in all communities, these gun laws did not equalize the consequences on a relative scale, and disadvantaged communities remained disproportionately impacted. While legislation is necessary, it may not be sufficient to solve the problem of assault-related firearm deaths among children and adolescents.  Authors: Deepika Nehra, M.D., of the University ...

Cannabis use disorder and subsequent risk of psychotic and nonpsychotic unipolar depression and bipolar disorder

2023-05-24
About The Study: This study of 6.6 million individuals in Demark found that cannabis use disorder was associated with an increased risk of psychotic and nonpsychotic bipolar disorder and unipolar depression. These findings may inform policies regarding the legal status and control of cannabis use. Authors: Oskar Hougaard Jefsen, M.D., of Aarhus University Hospital–Psychiatry in Aarhus, Denmark, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (10.1001/jamapsychiatry.2023.1256) Editor’s ...

Quantum matter breakthrough: Tuning density waves

Quantum matter breakthrough: Tuning density waves
2023-05-24
“Cold atomic gases were well known in the past for the ability to ‘program’ the interactions between atoms,” says Professor Jean-Philippe Brantut at EPFL. “Our experiment doubles this ability!” Working with the group of Professor Helmut Ritsch at the University of Innsbruck, they have made a breakthrough that can impact not only quantum research but quantum-based technologies in the future. Density waves Scientists have long been interested in understanding how materials self-organize into complex structures, such as crystals. In the often-arcane world of quantum physics, ...

Fewer suicides among boys in regions with more bipolar diagnoses

2023-05-24
Bipolar disorder underlies roughly five percent of all suicides among young people. Previous studies also show that there is often a long delay between the onset of bipolarism and its correct diagnosis and treatment. Researchers at Karolinska Institutet now show that fewer boys commit suicide in Swedish regions where bipolar diagnoses are more common. The study, which is published in JAMA Psychiatry, could contribute to more proactive care for reducing the number of suicides. “Bipolar disorder is often more distressing for people who develop it early in life and is one of the psychiatric disorders most associated with suicide risk,” says ...

Scientists find first evidence for new superconducting state in Ising superconductor

Scientists find first evidence for new superconducting state in Ising superconductor
2023-05-24
In a ground-breaking experiment, scientists from the University of Groningen, together with colleagues from the Dutch universities of Nijmegen and Twente and the Harbin Institute of Technology (China), have discovered the existence of a superconductive state that was first predicted in 2017. They present evidence for a special variant of the FFLO superconductive state on 24 May in the journal Nature. This discovery could have significant applications, particularly in the field of superconducting electronics. The lead author of the paper is Professor Justin Ye, who heads the Device Physics of Complex Materials group at the University of Groningen. Ye and his team have ...

LAST 30 PRESS RELEASES:

4D Medicine raises £3.4 million for unique biomaterial platform

Ancient marine animal had inventive past despite being represented by few species, new study finds

Quantum sensor for the atomic world developed through international scientific collaboration

The research was wrong: study shows moderate drinking won’t lengthen your life

Save your data on printable magnetic devices? New laser technique’s twist might make this reality

Early onset dementia more common than previously reported – the incidence of Alzheimer’s disease seems to be on the rise

Pesticides potentially as bad as smoking for increased risk in certain cancers

NUS researchers develop new battery-free technology to power electronic devices using ambient radiofrequency signals

New protein discovery may influence future cancer treatment

Timing matters: Scripps Research study shows ways to improve health alerts

New gene therapy approach shows promise for Duchenne muscular dystrophy

Chemical analyses find hidden elements from renaissance astronomer Tycho Brahe’s alchemy laboratory

Pacific Northwest launches clean hydrogen energy hub

Tiny deletion in heart muscle protein briefly affects embryonic ventricles but has long-term effects on adult atrial fibrillation

Harms of prescribing NSAIDs to high risk groups estimated to cost NHS £31m over 10 years

Wearing a face mask in public spaces cuts risk of common respiratory symptoms, suggests Norway study

Some private biobanks overinflating the value of umbilical cord blood banking in marketing to expectant parents

New research in fatty liver disease aims to help with early intervention

Genetics reveal ancient trade routes and path to domestication of the Four Corners potato

SNIS 2024: New study shows critical improvements in treating rare eye cancer in children

Wearable devices can increase health anxiety. Could they adversely affect health?

Addressing wounds of war

Rice researchers develop innovative battery recycling method

It’s got praying mantis eyes

Stroke recovery: It’s in the genes

Foam fluidics showcase Rice lab’s creative approach to circuit design

Montana State scientists publish evidence for new groups of methane-producing organisms

Daily rhythms depend on receptor density in biological clock

New England Journal of Medicine publishes outcomes from practice-changing E1910 trial for patients with BCR::ABL1-negative B-cell precursor acute lymphoblastic leukemia

Older adults want to cut back on medication, but study shows need for caution

[Press-News.org] Tambourine announces the ALS breakthrough research fund, releases inaugural request for proposals